Evaxion Biotech AS (EVAX)
3.67
+0.07
(+1.96%)
USD |
NASDAQ |
May 31, 16:00
3.62
-0.05
(-1.36%)
After-Hours: 20:00
Evaxion Biotech Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2022 | -0.744M |
March 31, 2022 | -1.162M |
December 31, 2021 | -1.33M |
September 30, 2021 | -1.415M |
Date | Value |
---|---|
June 30, 2021 | -1.089M |
March 31, 2021 | -0.639M |
December 31, 2020 | -0.393M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.415M
Minimum
Sep 2021
-0.393M
Maximum
Dec 2020
-0.9674M
Average
-1.089M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Ascendis Pharma A/S | 91.67M |
DBV Technologies SA | -2.982M |
Cellectis SA | -17.79M |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | -0.3289M |